首页> 外国专利> Marker and its use for determining the effectiveness of application of cancer therapy including cancer immunotherapy to cancer patients

Marker and its use for determining the effectiveness of application of cancer therapy including cancer immunotherapy to cancer patients

机译:标记及其在确定对癌症患者进行癌症治疗(包括癌症免疫治疗)的有效性方面的用途

摘要

PROBLEM TO BE SOLVED: To provide a new technique for judging the effectiveness of application of a cancer treatment method including cancer immunotherapy to a cancer patient. SOLUTION: The use of Choleterol 25-hydroxylase (Ch25H) gene, Ch25H protein, or 25-hydroxycholesterol (25OHC) as a marker for determining the effectiveness of application of cancer treatment methods including cancer immunotherapy to cancer patients. [Selection diagram] None
机译:要解决的问题:提供一种新技术来判断对癌症患者应用包括癌症免疫疗法在内的癌症治疗方法的有效性。解决方案:使用胆固醇25-羟化酶(Ch25H)基因,Ch25H蛋白或25-羟胆固醇(25OHC)作为标记物,以确定对癌症患者应用包括癌症免疫疗法在内的癌症治疗方法的有效性。 [选择图]无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号